Eric Shieh, MD
Ophthalmology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 33
- 9 carriers
- Office
- 1
Offices
1 location · Advanced Eye Associates · 3 clinicians in this group
Looking this up.
Plans that list them
33 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shieh’s office at (408) 923-8138 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
33 of 33 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$163,373
Medicare paid this office $163,373 for 586 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 286 | $48,800 | $105 |
| Removal of cataract with insertion of prosthetic lens | 39 | $31,700 | $520 |
| Short return visit (20+ min) | 229 | $15,980 | $59 |
| Established patient complete exam of visual system | 123 | $11,650 | $89 |
| Exam of visual field with extended testing | 145 | $10,515 | $56 |
See all 16 services
| Return visit (30+ min) | 286 | $48,800 | $105 |
| Removal of cataract with insertion of prosthetic lens | 39 | $31,700 | $520 |
| Short return visit (20+ min) | 229 | $15,980 | $59 |
| Established patient complete exam of visual system | 123 | $11,650 | $89 |
| Exam of visual field with extended testing | 145 | $10,515 | $56 |
| Closure of tear duct opening using plug | 24 | $6,895 | $181 |
| Imaging of retina | 123 | $4,922 | $32 |
| Imaging of optic nerve | 129 | $4,059 | $28 |
| New patient visit (45+ min) | 35 | $3,886 | $111 |
| New patient visit (30+ min) | 26 | $2,195 | $84 |
| New patient complete exam of visual system | 12 | $1,517 | $126 |
| Measurement of corneal curvature and depth of eye | 41 | $1,466 | $36 |
| Exam of the internal drainage system of eye | 30 | $750 | $25 |
| Measurement of corneal curvature and depth of eye | 24 | $694 | $29 |
| Removal of eyelashes using forceps | 23 | $514 | $15 |
| Ultrasound scan of cornea to determine thickness | 37 | $366 | $10 |
Procedures Medicare counted
| Cataract surgery | 56 | More than 65% of doctors who do this |
Who their Medicare patients are
586 Original Medicare patients in 2024. Average age 77 · Under 65 4% · 85 and older 19% · Women 63% · Also on Medicaid 83% · Health risk score 1.20. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 75% · Diabetes 52% · Chronic kidney disease 27% · Coronary heart disease 17% · Heart failure 10% · COPD 10% · Cancer 9% · Atrial fibrillation 9% · Depression 9% · Dementia 7% · Stroke 6%.
The office billed $474,197, Medicare allowed $246,090 and paid $163,373; for 1,751 services of 27 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 586 | 1,751 | 77 | 1.20 | $474,197 | $163,373 |
| 2023 | 619 | 1,883 | 76 | 1.26 | $493,035 | $167,588 |
| 2022 | 721 | 2,280 | 76 | 1.17 | $669,187 | $201,462 |
| 2021 | 538 | 1,636 | 74 | 1.21 | $590,263 | $188,254 |
| 2020 | 408 | 1,081 | 74 | 1.45 | $326,294 | $99,978 |
| 2019 | 206 | 351 | 76 | 1.46 | $101,375 | $37,669 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Removal of cataract with insertion of prosthetic lens | 44 | $35,035 | $531 |
| Short return visit (20+ min) | 378 | $34,407 | $69 |
| Return visit (30+ min) | 230 | $27,684 | $99 |
| Established patient complete exam of visual system | 141 | $15,637 | $105 |
| Exam of visual field with extended testing | 116 | $8,600 | $54 |
| Closure of tear duct opening using plug | 27 | $8,404 | $138 |
| Imaging of retina | 145 | $6,235 | $33 |
| Imaging of optic nerve | 130 | $4,952 | $29 |
| New patient visit (45+ min) | 30 | $2,867 | $96 |
| Measurement of corneal curvature and depth of eye | 49 | $1,954 | $39 |
| Established patient problem focused exam of visual system | 33 | $1,418 | $43 |
| New patient visit (30+ min) | 14 | $985 | $70 |
| Measurement of corneal curvature and depth of eye | 22 | $644 | $29 |
| Removal of eyelashes using forceps | 24 | $624 | $17 |
| Exam of the internal drainage system of eye | 28 | $595 | $21 |
| Ultrasound scan of cornea to determine thickness | 21 | $202 | $10 |
2022: 19 services
| Removal of cataract with insertion of prosthetic lens | 56 | $41,436 | $493 |
| Established patient problem focused exam of visual system | 389 | $33,877 | $62 |
| Established patient complete exam of visual system | 296 | $29,280 | $90 |
| Short return visit (20+ min) | 147 | $12,281 | $81 |
| Injection of drug into eye | 28 | $8,087 | $97 |
| Imaging of retina | 162 | $7,811 | $33 |
| Closure of tear duct opening using plug | 30 | $7,794 | $111 |
| Return visit (30+ min) | 50 | $6,223 | $113 |
| Exam of visual field with extended testing | 103 | $5,889 | $49 |
| Removal of recurring cataract in lens capsule using a laser | 11 | $4,696 | $313 |
| New patient visit (45+ min) | 45 | $4,500 | $100 |
| New patient complete exam of visual system | 50 | $4,374 | $87 |
| Imaging of optic nerve | 123 | $4,024 | $27 |
| Injection, bevacizumab, 10 mg | 24 | $3,785 | None |
| Measurement of corneal curvature and depth of eye | 59 | $2,170 | $37 |
| Exam of the internal drainage system of eye | 37 | $890 | $23 |
| Measurement of corneal curvature and depth of eye | 29 | $836 | $29 |
| Removal of eyelashes using forceps | 31 | $680 | $15 |
| Ultrasound scan of cornea to determine thickness | 27 | $252 | $9 |
2021: 17 services
| Removal of cataract with insertion of prosthetic lens | 41 | $34,338 | $528 |
| Established patient problem focused exam of visual system | 280 | $32,493 | $75 |
| Established patient complete exam of visual system | 185 | $19,992 | $97 |
| New patient complete exam of visual system | 107 | $9,717 | $91 |
| Injection of drug into eye | 18 | $9,052 | $106 |
| New patient visit (45+ min) | 67 | $6,611 | $99 |
| Imaging of retina | 86 | $4,855 | $37 |
| Closure of tear duct opening using plug | 14 | $4,114 | $118 |
| Exam of visual field with extended testing | 62 | $3,911 | $58 |
| Injection, bevacizumab, 10 mg | 15 | $3,457 | None |
| Imaging of optic nerve | 89 | $3,167 | $33 |
| Measurement of corneal curvature and depth of eye | 40 | $2,194 | $54 |
| New patient visit (30+ min) | 26 | $1,648 | $63 |
| Measurement of corneal curvature and depth of eye | 27 | $823 | $29 |
| Exam of the internal drainage system of eye | 25 | $617 | $25 |
| Removal of eyelashes using forceps | 12 | $346 | $14 |
| Ultrasound scan of cornea to determine thickness | 20 | $192 | $10 |
2020: 16 services
| Established patient problem focused exam of visual system | 176 | $15,229 | $65 |
| Removal of cataract with insertion of prosthetic lens | 17 | $11,995 | $522 |
| Established patient complete exam of visual system | 102 | $11,131 | $96 |
| New patient complete exam of visual system | 83 | $8,293 | $100 |
| Injection of drug into eye | 13 | $6,380 | $97 |
| Short return visit (20+ min) | 66 | $5,926 | $69 |
| New patient visit (45+ min) | 55 | $4,146 | $75 |
| Injection, bevacizumab, 10 mg | 13 | $3,721 | None |
| Imaging of retina | 52 | $2,394 | $33 |
| Exam of visual field with extended testing | 36 | $1,919 | $52 |
| Measurement of corneal curvature and depth of eye | 31 | $1,718 | $55 |
| New patient visit (30+ min) | 23 | $1,285 | $56 |
| Imaging of optic nerve | 38 | $1,191 | $29 |
| Removal of eyelashes using forceps | 13 | $593 | $23 |
| Exam of the internal drainage system of eye | 15 | $358 | $20 |
| Ultrasound scan of cornea to determine thickness | 12 | $120 | $10 |
2019: 8 services
| Established patient problem focused exam of visual system | 83 | $8,408 | $87 |
| New patient complete exam of visual system | 62 | $7,975 | $129 |
| Established patient complete exam of visual system | 50 | $5,581 | $112 |
| Short return visit (20+ min) | 15 | $1,354 | $64 |
| Exam of visual field with extended testing | 13 | $908 | $65 |
| Photography of the retina | 11 | $556 | $51 |
| Imaging of retina | 12 | $485 | $40 |
| Imaging of optic nerve | 12 | $401 | $33 |
Medicaid work
$21,780 in 2024
Medicaid paid $21,780 for 2,038 billed services this clinician did in 2024, up to 61 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 232 | $6,411 |
| Return visit (30+ min) | 391 | $5,343 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 269 | $2,060 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 210 | $1,670 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 491 | $1,440 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 96 | $1,332 |
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 17 | $1,223 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 203 | $1,043 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 59 | $604 |
| New patient visit (30+ min) | 44 | $349 |
| New patient visit (45+ min) | 26 | $307 |
| 2024 | 2,038 | 11 | 61 | $21,780 |
| 2023 | 3,216 | 11 | 79 | $28,607 |
| 2022 | 3,261 | 13 | 134 | $24,711 |
| 2021 | 3,482 | 14 | 110 | $22,419 |
| 2020 | 1,497 | 10 | 63 | $7,648 |
| 2019 | 72 | 2 | 27 | $0 |
| 2018 | 15 | 1 | 15 | $0 |
See the largest Medicaid services in earlier years
2023
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 92 | $6,676 |
| Short return visit (20+ min) | 553 | $6,313 |
| Return visit (30+ min) | 289 | $3,328 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 745 | $2,850 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 310 | $1,825 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 296 | $1,808 |
| New patient visit (45+ min) | 200 | $1,743 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 355 | $1,301 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 61 | $1,132 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 155 | $1,036 |
| New patient visit (30+ min) | 160 | $594 |
2022
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 1,213 | $8,494 |
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 90 | $5,194 |
| Intravitreal injection of a pharmacologic agent (separate procedure) | 68 | $1,936 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 234 | $1,764 |
| New patient visit (45+ min) | 350 | $1,588 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 298 | $1,271 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 214 | $1,171 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 140 | $999 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 281 | $876 |
| New patient visit (30+ min) | 192 | $693 |
| Injection, bevacizumab, 10 mg | 59 | $455 |
| Short return visit (20+ min) | 109 | $238 |
2021
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 123 | $9,692 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 1,145 | $4,469 |
| New patient visit (30+ min) | 381 | $1,788 |
| Intravitreal injection of a pharmacologic agent (separate procedure) | 144 | $1,522 |
| New patient visit (45+ min) | 538 | $1,239 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 87 | $784 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 170 | $710 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 203 | $614 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 311 | $533 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 227 | $468 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 12 | $296 |
| Injection, bevacizumab, 10 mg | 77 | $234 |
2020
| New patient visit (30+ min) | 287 | $1,677 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 376 | $1,634 |
| Return visit (30+ min) | 168 | $1,382 |
| New patient visit (45+ min) | 248 | $1,259 |
| Intravitreal injection of a pharmacologic agent (separate procedure) | 131 | $928 |
| Injection, bevacizumab, 10 mg | 102 | $229 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 32 | $229 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 70 | $198 |
| Short return visit (20+ min) | 27 | $108 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 56 | $5 |
2019
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 23 | $0 |
| New patient visit (30+ min) | 49 | $0 |
2018
| Short return visit | 15 | $0 |
Drugs they prescribed that Part D paid
$2,198,941
Pharmacies billed $2,198,941 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 6,781) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
2,820 generic and 3,961 brand-name prescriptions · $2,198,941 in drug cost · 12 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Restasis | 1,181 | $1,156,170 | $979 |
| Cyclosporine | 422 | $260,652 | $618 |
| Lumigan | 308 | $128,119 | $416 |
| Cequa | 160 | $124,808 | $780 |
| Xiidra | 113 | $122,640 | $1,085 |
See all 43 drugs
| Restasis | 1,181 | $1,156,170 | $979 |
| Cyclosporine | 422 | $260,652 | $618 |
| Lumigan | 308 | $128,119 | $416 |
| Cequa | 160 | $124,808 | $780 |
| Xiidra | 113 | $122,640 | $1,085 |
| Rocklatan | 99 | $50,273 | $508 |
| Miebo | 58 | $41,711 | $719 |
| Rhopressa | 80 | $33,431 | $418 |
| Simbrinza | 121 | $27,162 | $224 |
| Xdemvy | 13 | $24,158 | $1,858 |
| Brimonidine | 242 | $16,756 | $69 |
| Tyrvaya | 24 | $16,652 | $694 |
| Latanoprost | 1,037 | $13,295 | $13 |
| Eysuvis | 23 | $13,100 | $570 |
| Fluorometholone | 187 | $12,260 | $66 |
| Prednisolone Acetate | 387 | $11,961 | $31 |
| Travoprost | 91 | $11,495 | $126 |
| Alphagan P | 36 | $11,153 | $310 |
| Zerviate | 14 | $10,072 | $719 |
| Vyzulta | 18 | $9,472 | $526 |
| Azopt | 13 | $9,296 | $715 |
| Azelastine | 391 | $9,232 | $24 |
| Brimonidine Tartrate-Timolol | 43 | $9,020 | $210 |
| Combigan | 19 | $8,816 | $464 |
| Moxifloxacin | 300 | $7,260 | $24 |
| Tafluprost | 46 | $6,517 | $142 |
| Brinzolamide | 22 | $5,671 | $258 |
| Prolensa | 17 | $5,612 | $330 |
| Lotemax Sm | 16 | $5,154 | $322 |
| Dorzolamide-Timolol | 31 | $5,141 | $166 |
| Loteprednol Etabonate | 30 | $4,883 | $163 |
| Dorzolamide-Timolol | 203 | $3,622 | $18 |
| Diclofenac | 254 | $2,870 | $11 |
| Timolol Maleate | 315 | $2,600 | $8 |
| Bromfenac | 11 | $2,495 | $227 |
| Dorzolamide | 124 | $2,021 | $16 |
| Erythromycin | 170 | $1,851 | $11 |
| Acetazolamide Er | 24 | $984 | $41 |
| Atropine Sulfate | 19 | $821 | $43 |
| Ketorolac Tromethamine | 13 | $405 | $31 |
| Valacyclovir | 15 | $225 | $15 |
| Neomycin-Polymyxin-Dexameth | 13 | $217 | $17 |
| Acyclovir | 15 | $164 | $11 |
Year by year
| 2024 | 6,781 | 1,127 | 0% (0) | 58% | $2,198,941 |
| 2023 | 6,230 | 1,141 | 0% (0) | 60% | $2,451,884 |
| 2022 | 5,605 | 1,146 | 0% (0) | 58% | $1,968,318 |
| 2021 | 3,836 | 803 | 0% (0) | 55% | $837,790 |
| 2020 | 2,564 | 517 | 0% (0) | 59% | $562,136 |
| 2019 | 552 | 213 | 0% (0) | 58% | $82,829 |
| 2018 | 114 | 48 | 0% (0) | 53% | $13,418 |
| 2017 | 87 | 30 | 0% (0) | 43% | $9,272 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 40 drugs
| Restasis | 1,043 | $1,274,028 | $1,222 |
| Cyclosporine | 309 | $203,586 | $659 |
| Cequa | 198 | $176,993 | $894 |
| Lumigan | 313 | $134,313 | $429 |
| Xiidra | 76 | $96,888 | $1,275 |
| Rocklatan | 98 | $57,919 | $591 |
| Alphagan P | 170 | $53,848 | $317 |
| Prolensa | 129 | $45,343 | $351 |
| Tyrvaya | 52 | $45,213 | $869 |
| Eysuvis | 60 | $36,891 | $615 |
| Zerviate | 34 | $26,276 | $773 |
| Simbrinza | 100 | $25,857 | $259 |
| Rhopressa | 47 | $23,795 | $506 |
| Latanoprost | 809 | $22,538 | $28 |
| Travoprost | 93 | $21,314 | $229 |
| Ilevro | 52 | $20,406 | $392 |
| Azelastine | 362 | $15,370 | $42 |
| Combigan | 26 | $14,339 | $551 |
| Azopt | 22 | $13,403 | $609 |
| Lotemax Sm | 40 | $12,856 | $321 |
| Prednisolone Acetate | 277 | $12,499 | $45 |
| Fluorometholone | 148 | $12,167 | $82 |
| Olopatadine | 264 | $10,665 | $40 |
| Moxifloxacin | 246 | $9,073 | $37 |
| Brimonidine | 163 | $9,026 | $55 |
| Brinzolamide | 26 | $8,285 | $319 |
| Loteprednol Etabonate | 29 | $6,865 | $237 |
| Dorzolamide-Timolol | 171 | $6,844 | $40 |
| Tafluprost | 40 | $5,964 | $149 |
| Brimonidine Tartrate-Timolol | 27 | $4,811 | $178 |
| Bepotastine Besilate | 18 | $4,689 | $261 |
| Dorzolamide | 107 | $3,856 | $36 |
| Timolol Maleate | 235 | $3,339 | $14 |
| Erythromycin | 171 | $2,925 | $17 |
| Acetazolamide Er | 26 | $1,868 | $72 |
| Diclofenac | 62 | $1,026 | $17 |
| Ketorolac Tromethamine | 25 | $780 | $31 |
| Neomycin-Polymyxin-Dexameth | 25 | $416 | $17 |
| Acyclovir | 14 | $169 | $12 |
| Cromolyn | 11 | $127 | $12 |
2022: 44 drugs
| Restasis | 967 | $1,140,261 | $1,179 |
| Cequa | 109 | $95,080 | $872 |
| Lumigan | 193 | $87,342 | $453 |
| Cyclosporine | 112 | $87,095 | $778 |
| Xiidra | 93 | $77,851 | $837 |
| Alphagan P | 158 | $42,225 | $267 |
| Prolensa | 122 | $40,423 | $331 |
| Rocklatan | 71 | $38,698 | $545 |
| Eysuvis | 57 | $36,763 | $645 |
| Azelastine | 336 | $20,598 | $61 |
| Rhopressa | 47 | $20,499 | $436 |
| Tyrvaya | 25 | $20,087 | $803 |
| Olopatadine | 289 | $19,203 | $66 |
| Combigan | 50 | $18,322 | $366 |
| Latanoprost | 692 | $17,188 | $25 |
| Zerviate | 22 | $15,790 | $718 |
| Travoprost | 66 | $14,848 | $225 |
| Fluorometholone | 178 | $14,608 | $82 |
| Prednisolone Acetate | 301 | $14,491 | $48 |
| Ilevro | 43 | $14,432 | $336 |
| Lotemax Sm | 51 | $13,648 | $268 |
| Loteprednol Etabonate | 62 | $13,073 | $211 |
| Simbrinza | 49 | $10,813 | $221 |
| Moxifloxacin | 268 | $10,535 | $39 |
| Bepotastine Besilate | 22 | $10,414 | $473 |
| Brimonidine Tartrate-Timolol | 25 | $6,469 | $259 |
| Vyzulta | 14 | $6,260 | $447 |
| Brinzolamide | 21 | $6,194 | $295 |
| Inveltys | 14 | $5,180 | $370 |
| Besivance | 24 | $4,957 | $207 |
| Flarex | 27 | $4,287 | $159 |
| Timolol Maleate | 190 | $4,085 | $22 |
| Brimonidine | 192 | $3,998 | $21 |
| Dorzolamide | 109 | $3,319 | $30 |
| Zioptan | 12 | $3,205 | $267 |
| Erythromycin | 181 | $2,768 | $15 |
| Dorzolamide-Timolol | 68 | $2,480 | $36 |
| Diclofenac | 98 | $2,308 | $24 |
| Atropine Sulfate | 23 | $1,657 | $72 |
| Acetazolamide Er | 23 | $1,210 | $53 |
| Neomycin-Polymyxin-Dexameth | 63 | $782 | $12 |
| Ketorolac Tromethamine | 13 | $631 | $49 |
| Acyclovir | 14 | $301 | $21 |
| Polymyxin B Sul-Trimethoprim | 11 | $105 | $10 |
2021: 34 drugs
| Restasis | 571 | $458,941 | $804 |
| Ilevro | 135 | $41,509 | $307 |
| Lumigan | 83 | $35,106 | $423 |
| Cequa | 42 | $25,735 | $613 |
| Rocklatan | 62 | $25,130 | $405 |
| Olopatadine | 383 | $23,198 | $61 |
| Alphagan P | 82 | $22,060 | $269 |
| Xiidra | 33 | $21,946 | $665 |
| Inveltys | 33 | $14,167 | $429 |
| Combigan | 45 | $13,498 | $300 |
| Prednisolone Acetate | 239 | $10,660 | $45 |
| Travoprost | 48 | $10,044 | $209 |
| Besivance | 53 | $10,028 | $189 |
| Latanoprost | 556 | $9,809 | $18 |
| Loteprednol Etabonate | 39 | $9,657 | $248 |
| Azelastine | 204 | $9,380 | $46 |
| Lotemax Sm | 21 | $7,120 | $339 |
| Rhopressa | 26 | $7,032 | $270 |
| Lotemax | 23 | $6,911 | $300 |
| Simbrinza | 25 | $6,469 | $259 |
| Flarex | 36 | $5,542 | $154 |
| Brinzolamide | 18 | $5,356 | $298 |
| Fluorometholone | 69 | $5,083 | $74 |
| Moxifloxacin | 152 | $4,574 | $30 |
| Prolensa | 12 | $3,601 | $300 |
| Brimonidine | 171 | $3,311 | $19 |
| Erythromycin | 201 | $2,996 | $15 |
| Dorzolamide | 91 | $2,320 | $25 |
| Timolol Maleate | 107 | $1,449 | $14 |
| Neomycin-Polymyxin-Dexameth | 67 | $1,009 | $15 |
| Dorzolamide-Timolol | 33 | $833 | $25 |
| Ketorolac Tromethamine | 24 | $713 | $30 |
| Atropine Sulfate | 12 | $521 | $43 |
| Diclofenac | 22 | $326 | $15 |
2020: 31 drugs
| Restasis | 364 | $300,283 | $825 |
| Cequa | 94 | $52,141 | $555 |
| Xiidra | 17 | $14,192 | $835 |
| Pazeo | 58 | $14,144 | $244 |
| Lumigan | 52 | $13,995 | $269 |
| Rocklatan | 43 | $13,434 | $312 |
| Alphagan P | 43 | $12,518 | $291 |
| Prednisolone Acetate | 215 | $12,494 | $58 |
| Lotemax | 43 | $10,803 | $251 |
| Olopatadine | 169 | $10,005 | $59 |
| Travoprost | 64 | $9,782 | $153 |
| Ilevro | 28 | $8,107 | $290 |
| Travatan Z | 24 | $5,501 | $229 |
| Moxifloxacin | 129 | $5,262 | $41 |
| Fluorometholone | 62 | $5,244 | $85 |
| Simbrinza | 25 | $5,136 | $205 |
| Azopt | 14 | $4,882 | $349 |
| Combigan | 23 | $4,831 | $210 |
| Latanoprost | 308 | $4,209 | $14 |
| Bepreve | 16 | $3,793 | $237 |
| Ketorolac Tromethamine | 86 | $3,506 | $41 |
| Azelastine | 113 | $3,315 | $29 |
| Besivance | 17 | $3,120 | $184 |
| Brimonidine | 65 | $2,210 | $34 |
| Flarex | 14 | $2,093 | $150 |
| Dorzolamide | 53 | $1,724 | $33 |
| Erythromycin | 124 | $1,668 | $13 |
| Dorzolamide-Timolol | 50 | $1,488 | $30 |
| Timolol Maleate | 67 | $712 | $11 |
| Neomycin-Polymyxin-Dexameth | 27 | $497 | $18 |
| Diclofenac | 25 | $363 | $15 |
2019: 15 drugs
| Restasis | 49 | $36,082 | $736 |
| Prednisolone Acetate | 90 | $4,996 | $56 |
| Brimonidine | 24 | $4,105 | $171 |
| Travatan Z | 15 | $2,916 | $194 |
| Lumigan | 12 | $2,749 | $229 |
| Simbrinza | 14 | $2,596 | $185 |
| Ketorolac Tromethamine | 26 | $1,072 | $41 |
| Moxifloxacin | 27 | $1,068 | $40 |
| Dorzolamide-Timolol | 27 | $910 | $34 |
| Latanoprost | 41 | $692 | $17 |
| Olopatadine | 15 | $644 | $43 |
| Erythromycin | 33 | $512 | $16 |
| Dorzolamide | 11 | $339 | $31 |
| Ofloxacin | 15 | $245 | $16 |
| Timolol Maleate | 14 | $120 | $9 |
2018: 4 drugs
| Brimonidine | 16 | $7,345 | $459 |
| Prednisolone Acetate | 24 | $1,840 | $77 |
| Ketorolac Tromethamine | 11 | $225 | $20 |
| Latanoprost | 15 | $146 | $10 |
2017: 4 drugs
| Brimonidine | 15 | $3,849 | $257 |
| Alphagan P | 11 | $3,309 | $301 |
| Latanoprost | 22 | $272 | $12 |
| Timolol Maleate | 11 | $185 | $17 |
Money from drug and device companies
$1,258 in 2025
| 2025 | 9 | 68 | None | $1,258 |
| 2024 | 12 | 55 | None | $1,089 |
| 2023 | 12 | 51 | None | $1,741 |
| 2022 | 10 | 57 | None | $1,137 |
| 2021 | 10 | 34 | None | $763 |
| 2020 | 8 | 31 | None | $414 |
| 2019 | 8 | 16 | None | $1,075 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Tarsus Pharmaceuticals | Xdemvy | $285 | 28 payments
|
| Alcon Vision | Rocklatan | $241 | 11 payments
|
| Abbvie | Lumigan | $240 | 8 payments
|
| Bausch & Lomb Americas | Miebo | $185 | 8 payments
|
| Amgen | Tepezza | $169 | 8 payments
|
| Oyster Point Pharma | Tyrvaya | $55 | 2 payments
|
See all 68 published payments
| Bausch & Lomb Americas | Meals · 2025-12-19 | Miebo | $22 |
| Tarsus Pharmaceuticals | Meals · 2025-12-12 | Xdemvy | $7 |
| Tarsus Pharmaceuticals | Meals · 2025-12-03 | None | $5 |
| Tarsus Pharmaceuticals | Meals · 2025-12-03 | Xdemvy | $22 |
| Amgen | Meals · 2025-11-24 | Tepezza | $9 |
| Tarsus Pharmaceuticals | Meals · 2025-11-24 | Xdemvy | $8 |
| Oyster Point Pharma | Meals · 2025-11-17 | Tyrvaya | $23 |
| Alcon Vision | Meals · 2025-11-04 | Eysuvis | $11 |
| Bausch & Lomb Americas | Meals · 2025-10-31 | Vyzulta | $23 |
| Abbvie | Meals · 2025-10-30 | Lumigan | $34 |
| Tarsus Pharmaceuticals | Meals · 2025-10-29 | Xdemvy | $9 |
| Tarsus Pharmaceuticals | Meals · 2025-10-22 | Xdemvy | $8 |
| Bausch & Lomb Americas | Meals · 2025-10-22 | Miebo | $24 |
| Alcon Vision | Meals · 2025-10-10 | Clareon Panoptix Pro | $28 |
| Tarsus Pharmaceuticals | Meals · 2025-10-03 | Xdemvy | $8 |
| Amgen | Meals · 2025-10-01 | Tepezza | $27 |
| Tarsus Pharmaceuticals | Meals · 2025-09-24 | Xdemvy | $8 |
| Alcon Vision | Meals · 2025-09-23 | Tryptyr | $32 |
| Tarsus Pharmaceuticals | Meals · 2025-09-17 | Xdemvy | $8 |
| Abbvie | Meals · 2025-09-16 | Lumigan | $30 |
| Tarsus Pharmaceuticals | Meals · 2025-09-09 | Xdemvy | $8 |
| Sun Pharmaceutical Industries | Meals · 2025-09-09 | Cequa | $32 |
| Tarsus Pharmaceuticals | Meals · 2025-09-03 | Xdemvy | $8 |
| Tarsus Pharmaceuticals | Meals · 2025-08-27 | Xdemvy | $9 |
| Bausch & Lomb Americas | Meals · 2025-08-26 | Miebo | $23 |
| Thea Pharma | Meals · 2025-08-22 | Iyuzeh | $24 |
| Tarsus Pharmaceuticals | Meals · 2025-08-20 | Xdemvy | $8 |
| Tarsus Pharmaceuticals | Meals · 2025-08-13 | Xdemvy | $7 |
| Alcon Vision | Meals · 2025-08-08 | Tryptyr | $32 |
| Amgen | Meals · 2025-08-05 | Tepezza | $27 |
| Abbvie | Meals · 2025-08-04 | Lumigan | $30 |
| Tarsus Pharmaceuticals | Meals · 2025-07-30 | Xdemvy | $8 |
| Tarsus Pharmaceuticals | Meals · 2025-07-22 | Xdemvy | $8 |
| Tarsus Pharmaceuticals | Meals · 2025-07-16 | Xdemvy | $8 |
| Abbvie | Meals · 2025-07-09 | Lumigan | $29 |
| Tarsus Pharmaceuticals | Meals · 2025-07-09 | Xdemvy | $8 |
| Alcon Vision | Meals · 2025-07-02 | Eysuvis | $25 |
| Bausch & Lomb Americas | Meals · 2025-07-01 | Miebo | $23 |
| Bausch & Lomb Americas | Meals · 2025-07-01 | Vyzulta | $20 |
| Tarsus Pharmaceuticals | Meals · 2025-06-18 | Xdemvy | $24 |
| Abbvie | Meals · 2025-06-11 | Lumigan | $28 |
| Tarsus Pharmaceuticals | Meals · 2025-06-11 | Xdemvy | $8 |
| Amgen | Meals · 2025-06-10 | Tepezza | $28 |
| RxSight | Meals · 2025-06-06 | Rxsight Contact Lens | $29 |
| Tarsus Pharmaceuticals | Meals · 2025-06-04 | Xdemvy | $8 |
| Alcon Vision | Meals · 2025-06-03 | Rocklatan | $23 |
| Abbvie | Meals · 2025-05-31 | Lumigan | $30 |
| Tarsus Pharmaceuticals | Meals · 2025-05-28 | Xdemvy | $8 |
| Tarsus Pharmaceuticals | Meals · 2025-05-21 | Xdemvy | $8 |
| Alcon Vision | Meals · 2025-05-20 | Eysuvis | $8 |
| Tarsus Pharmaceuticals | Meals · 2025-05-14 | Xdemvy | $8 |
| Abbvie | Meals · 2025-05-06 | Lumigan | $29 |
| Amgen | Meals · 2025-05-02 | Tepezza | $9 |
| Abbvie | Meals · 2025-05-01 | Lumigan | $29 |
| Tarsus Pharmaceuticals | Meals · 2025-04-30 | Xdemvy | $7 |
| Alcon Vision | Meals · 2025-04-23 | Rocklatan | $18 |
| Tarsus Pharmaceuticals | Meals · 2025-04-23 | Xdemvy | $27 |
| Bausch & Lomb Americas | Meals · 2025-04-23 | Miebo | $25 |
| Tarsus Pharmaceuticals | Meals · 2025-04-02 | Xdemvy | $8 |
| Amgen | Meals · 2025-03-21 | Tepezza | $10 |
| Alcon Vision | Meals · 2025-03-05 | Hydrus Microstent | $24 |
| Bausch & Lomb Americas | Meals · 2025-02-27 | Miebo | $25 |
| Oyster Point Pharma | Meals · 2025-02-26 | Tyrvaya | $32 |
| Alcon Vision | Meals · 2025-02-22 | Rocklatan | $10 |
| Amgen | Meals · 2025-02-14 | Tepezza | $28 |
| Alcon Vision | Meals · 2025-01-22 | Rocklatan | $31 |
| Tarsus Pharmaceuticals | Meals · 2025-01-15 | Xdemvy | $25 |
| Amgen | Meals · 2025-01-14 | Tepezza | $31 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,089
| Amgen | Tepezza | $190 | 13 payments
|
| Bausch & Lomb Americas | Miebo | $179 | 12 payments
|
| Abbvie | Lumigan | $174 | 7 payments
|
| Biotissue Holdings | None | $159 | 6 payments
|
| Sun Pharmaceutical Industries | Cequa | $93 | 4 payments
|
| Alcon Vision | Rocklatan | $78 | 4 payments
|
| Tarsus Pharmaceuticals | Xdemvy | $72 | 3 payments
|
| Sight Sciences | Omni Surgical System | $56 | 2 payments
|
| Mallinckrodt Hospital Products | Acthar | $29 | 1 payment
|
| Dompe US | Oxervate | $25 | 1 payment
|
| Thea Pharma | Iyuzeh | $20 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $14 | 1 payment
|
2023: $1,741
| Carl Zeiss Meditec USA | Lumera 700 | $587 | 4 payments
|
| Oyster Point Pharma | Tyrvaya | $247 | 6 payments
|
| Sun Pharmaceutical Industries | Cequa | $233 | 13 payments
|
| AbbVie | Lumigan | $155 | 5 payments
|
| Alcon Vision | Rocklatan | $127 | 6 payments
|
| Bausch & Lomb Americas | Vyzulta | $111 | 5 payments
|
| Horizon Therapeutics plc | Tepezza | $98 | 4 payments
|
| Novartis Pharmaceuticals | Xiidra | $48 | 2 payments
|
| Thea Pharma | Iyuzeh | $46 | 2 payments
|
| Biotissue Holdings | Prokera | $46 | 2 payments
|
| Sight Sciences | Omni Surgical System | $25 | 1 payment
|
| RxSight | Rxsight Contact Lens | $18 | 1 payment
|
2022: $1,137
| Sun Pharmaceutical Industries | Cequa | $223 | 11 payments
|
| Abbvie | Durysta | $192 | 11 payments
|
| Novartis Pharmaceuticals | Xiidra | $172 | 14 payments
|
| Oyster Point Pharma | Tyrvaya | $170 | 3 payments
|
| Bausch & Lomb Americas | Vyzulta | $127 | 6 payments
|
| Alcon Vision | Rhopressa | $94 | 4 payments
|
| Kala Pharmaceuticals | Inveltys | $80 | 4 payments
|
| Eyevance Pharmaceuticals | Flarex | $40 | 2 payments
|
| Dompe US | Oxervate | $25 | 1 payment
|
| Sight Sciences | Omni(R) Surgical System (US) | $13 | 1 payment
|
2021: $763
| Aerie Pharmaceuticals | Rhopressa | $181 | 6 payments
|
| Kala Pharmaceuticals | Inveltys | $115 | 7 payments
|
| Allergan | Durysta | $95 | 4 payments
|
| Sun Pharmaceutical Industries | Cequa | $89 | 4 payments
|
| Bausch & Lomb a division of Bausch Health US | Vyzulta | $87 | 4 payments
|
| Novartis Pharmaceuticals | Xiidra | $57 | 3 payments
|
| Sight Sciences | Omni(R) Surgical System (US) | $54 | 2 payments
|
| Tissuetech | Prokera | $41 | 2 payments
|
| Eyevance Pharmaceuticals | Tobradex St | $25 | 1 payment
|
| Ivantis | Hydrus Microstent | $21 | 1 payment
|
2020: $414
| Eyevance Pharmaceuticals | Flarex | $149 | 19 payments
|
| Aerie Pharmaceuticals | Rocklatan | $70 | 3 payments
|
| Bausch & Lomb a division of Bausch Health US | Lotemax Sm | $49 | 2 payments
|
| Kala Pharmaceuticals | Inveltys | $40 | 2 payments
|
| TissueTech | Prokera | $38 | 2 payments
|
| Ivantis | Hydrus | $25 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $23 | 1 payment
|
| Allergan | Restasis | $20 | 1 payment
|
2019: $1,075
| Alcon Vision | Acrysof | $386 | 4 payments
|
| Bausch & Lomb a division of Bausch Health US | Vyzulta | $319 | 5 payments
|
| Glaukos | Istent Inject Trabecular Micro-Bypass Stent System | $166 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $125 | 1 payment
|
| Aerie Pharmaceuticals | Rhopressa | $36 | 2 payments
|
| Omeros | Omidria | $19 | 1 payment
|
| Integra LifeSciences | Salto Talaris Total Ankle Prosthesis | $16 | 1 payment
|
| New World Medical | Ahmed Glaucoma Valve | $9 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1932581642
- Licence
- CA E1613206
- Trained
- Harvard Medical School, 2015
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 200 Jose Figueres Ave Ste 350, San Jose, CA, 95116
- NPI first listed
- 2015-06-18
- NPI last updated
- 2022-06-30
- NPI record certified
- 2022-06-30
This is when the NPI record was last certified, not a medical board exam.